We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Anavex Life Sciences
AVXL
$310M
| $799K | ﹤0.01% |
86,292
+2,320
| +3% | +$24.8K |
|
2252
Bank of Marin Bancorp
BMRC
$459M
| $799K | ﹤0.01% |
24,296
+138
| +0.6% | +$4.64K |
|
|
BAND
2253
Bandwidth Inc
BAND
$1.61B
| $798K | ﹤0.01% |
34,754
+1,490
| +4% | +$27.1K |
|
2254
Arcutis Biotherapeutics
ARQT
$3.18B
| $790K | ﹤0.01% |
53,377
+8,703
| +19% | +$152K |
|
2255
HCI Group
HCI
$2.41B
| $790K | ﹤0.01% |
19,957
+1,039
| +5% | +$38.3K |
|
2256
Allogene Therapeutics
ALLO
$694M
| $789K | ﹤0.01% |
125,502
-3,371
| -3% | -$31.2K |
|
2257
V2X
VVX
$2.65B
| $788K | ﹤0.01% |
19,096
+70
| +0.4% | +$2.77K |
|
2258
Equity Bancshares
EQBK
$1.05B
| $784K | ﹤0.01% |
23,985
+640
| +3% | +$22.1K |
|
|
ESMT
2259
DELISTED
EngageSmart, Inc.
ESMT
| $784K | ﹤0.01% |
44,540
+2,128
| +5% | +$39.1K |
|
2260
Brookdale Senior Living
BKD
$3.4B
| $781K | ﹤0.01% |
285,922
-1,764
| -0.6% | -$6.59K |
|
2261
Compass
COMP
$9.66B
| $777K | ﹤0.01% |
333,440
+6,811
| +2% | +$17.9K |
|
2262
Nurix Therapeutics
NRIX
$2.65B
| $777K | ﹤0.01% |
70,767
+677
| +1% | +$8.16K |
|
2263
Protagonist Therapeutics
PTGX
$9.44B
| $776K | ﹤0.01% |
71,153
+636
| +0.9% | +$5.37K |
|
2264
Life Time Group Holdings
LTH
$9.79B
| $774K | ﹤0.01% |
64,686
+932
| +1% | +$10.6K |
|
2265
Grid Dynamics Holdings
GDYN
$615M
| $772K | ﹤0.01% |
68,813
+10,468
| +18% | +$136K |
|
2266
Alector
ALEC
$199M
| $769K | ﹤0.01% |
83,302
+4,234
| +5% | +$36.9K |
|
|
DENN
2267
DELISTED
Denny's
DENN
| $768K | ﹤0.01% |
83,360
-1,201
| -1% | -$13K |
|
2268
Business First Bancshares
BFST
$1.03B
| $766K | ﹤0.01% |
34,612
+2,809
| +9% | +$64.4K |
|
2269
iShares MSCI USA Value Factor ETF
VLUE
$9.47B
| $766K | ﹤0.01% |
8,400
+5,900
| +236% | +$540K |
|
2270
CareDx
CDNA
$2.42B
| $763K | ﹤0.01% |
66,907
+2,027
| +3% | +$30K |
|
2271
OrthoPediatrics
KIDS
$595M
| $762K | ﹤0.01% |
19,188
+391
| +2% | +$16.3K |
|
|
PTVE
2272
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $762K | ﹤0.01% |
67,055
+650
| +1% | +$7.09K |
|
2273
Fluence Energy
FLNC
$2.44B
| $761K | ﹤0.01% |
44,373
+1,033
| +2% | +$16.3K |
|
|
URG
2274
Ur-Energy
URG
$556M
| $761K | ﹤0.01% |
662,061
-36,290
| -5% | -$44.2K |
|
|
RIDE
2275
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $761K | ﹤0.01% |
44,531
+28,197
| +173% | +$655K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.